Aligos Therapeutics Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Aligos Therapeutics is a clinical-stage biotechnology company focused on therapies for liver and viral diseases. Its pipeline targets chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis, obesity, and coronaviruses, reflecting a science-driven approach to addressing high unmet medical needs. Based in South San Francisco, California, the company is a mid-sized organization advancing research into therapies aimed at improving patient outcomes.

A recent development sees the company enter into an exclusive license agreement with Xiamen Amoytop Biotech to develop pevifoscorvir sodium in Greater China for chronic hepatitis B infection. The arrangement highlights ongoing efforts to advance its hepatitis B program and broaden its geographic footprint through partnerships.

Sign up for free to view info

Company overview Employee directory